|
|
|
LONDON (SHARECAST) - Shares in miner Antofagasta resumed their position near the top of the leaderboard after a brief dip into negative territory that came as commodity prices slipped in line with strength in the US dollar. US...
British drugmaker GlaxoSmithKline (GSK) Plc is planning to move part of its flu drug Relenza manufacture to China to better support the local market. "I hope that we will be able to shift some Relenza manufacture to China to...
| For more than a year, John Mark Felton chatted online with an Anchorage father of two, planning a visit to meet the family so he could molest a 6-year-old boy, according to documents filed in federal court. He talked about a...
As a result of successful events organised last year, a second Joint Scientific Forum, organised by the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), two of the most...
Five H1N1 patients resistant to Tamiflu * Possible person-to-person spread of resistant strain LONDON, Nov 20 (Reuters) - British health officials are investigating the likely person-to-person spread of a drug-resistant strain...
More than $160 billion worth of buyouts involving top drugmakers has already been inked in 2009. The buy-big strategy is the best way for pharma to bolster profit margins in the face of a flood of patent expirations, says a new...
AFTER DISSIDENT SHAREHOLDERS TOOK control of ICN Pharmaceuticals from founder Milan Panic seven years ago, the controversial entrepreneur said they had "destroyed what I dreamed." But since then, the renamed Valeant...
The London School of Hygiene & Tropical Medicine - This course aims to train students from a variety of academic backgrounds to work as statisticians in various sectors including higher education, research institutions, the...
PARTICIPANTS for the Penang Starwalk 2009 will be able to try the Breathe Right Nasal Strips which will be given out in their goodie bags. “The product is suitable for those who snore in their sleep,” said GlaxoSmithKline oral...
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This...
